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Abstract
Background: Dimeric human erythropoietin (dHuEPO) peptides are reported to exhibit significantly higher
biological activity than the monomeric form of recombinant EPO. The objective of this study was to produce
transgenic (tg) mice expressing dHuEPO and to investigate the characteristics of these mice.
Methods: A dHuEPO-expressing vector under the control of the goat beta-casein promoter, which produced a
dimer of human EPO molecules linked by a 2-amino acid peptide linker (Asp-Ile), was constructed and injected
into 1-cell fertilized embryos by microinjection. Mice were screened using genomic DNA samples obtained from
tail biopsies. Blood samples were obtained by heart puncture using heparinized tubes, and hematologic
parameters were assessed. Using the microarray analysis tool, we analyzed differences in gene expression in the
spleens of tg and control mice.
Results: A high rate of spontaneous abortion or death of the offspring was observed in the recipients of dHuEPO
embryos. We obtained 3 founder lines (#4, #11, and #47) of tg mice expressing the dHuEPO gene. However, only
one founder line showed stable germline integration and transmission, subsequently establishing the only
transgenic line (#11). We obtained 2 F1 mice and 3 F2 mice from line #11. The dHuEPO protein could not be
obtained because of repeated spontaneous abortions in the tg mice. Tg mice exhibited symptoms such as short
lifespan and abnormal blood composition. The red blood cell count, white blood cell count, and hematocrit levels
in the tg mice were remarkably higher than those in the control mice. The spleens of the tg mice (F1 and F2
females) were 11- and -21-fold larger than those of the control mice. Microarray analysis revealed 2,672 spleen-
derived candidate genes; more genes were downregulated than upregulated (849/764). Reverse transcriptase-
polymerase chain reaction (RT-PCR) and quantitative real-time PCR (qRT-PCR) were used for validating the results of
the microarray analysis of mRNA expression.
Conclusions: In conclusion, dHuEPO tg mice caused excessive erythrocytosis that led to abnormal blood composition,
short lifespan, and abnormal splenomegaly. Further, we identified 2,672 genes associated with splenomegaly by
microarray analysis. These results could be useful in the development of dHuEPO-producing tg animals.
Background
Erythropoietin (EPO), a 30.4-kDa glycoprotein hormone
secreted mainly by peritubular cells of the adult kidney,
is the major factor regulating red blood cell (RBC) pro-
duction [1]. Recombinant human EPO (rhEPO) has
been approved for the treatment of anemia resulting
from chronic renal failure, cancer chemotherapy, AIDS,
etc. [2-4]. Administration of rhEPO as a potential thera-
peutic agent can reduce the necessity for blood transfu-
sions and improve the patients’ quality of life. Although
rhEPO may be beneficial for the patients, the price of
such a treatment prevents its use as a long-term intrave-
nous treatment. Therefore, various strategies have been
used to stimulate erythropoiesis. Many approaches to
extend the half-life of EPO through genetic changes or
chemical modification of native EPO have been consid-
ered in detail [5,6]. All these strategies have shown
some effect on extending the half-life and enhancing the
activities of rhEPO. Particularly, dimerization of 2
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activity of the hormone; this is because the dimer has 2
high-affinity binding sites, resulting in better binding to
the EPO receptor than is observed with the monomeric
form of recombinant rhEPO [7-9]. Similarly, the longer
half-life of novel erythropoietin stimulating protein
(NESP), which was created by the introduction of 2
extra N-linked carbohydrate addition sites into the pri-
mary sequence of EPO, is likely to afford it a clinical
advantage over rhEPO by allowing less frequent dosing
in patients treated for anemia [10]. An EPO chimeric
protein, constructed by fusing the carboxyl-terminal
peptide of a human chorionic gonadotropin-b subunit
bearing 4 O-linked oligosaccharide recognition sites
with the coding sequence of human EPO cDNA, did not
show altered secretion, receptor binding affinity, or in
vitro bioactivity, but had significantly enhanced in vivo
potency and half-life [11]. We also studied the produc-
tion of rhEPO in mammalian cells and observed that
hyperglycosylated rhEPO (HGEPO) and dHuEPO have
higher erythropoietic activity than wild-type rhEPO,
both in vitro and in vivo [12-14].
Transgenic (tg) animals are an attractive alternative to
cell cultures for high-level, low-cost production of pro-
teins. The mammary gland is the most reasonable organ
for the production of recombinant proteins from trans-
genic organisms [15,16] and is suitable for synthesis of
large amounts of protein that can be easily collected
without causing harm to the animal [17]. Attempts have
been made to obtain transgenic mice showing enhanced
expression of the monomeric form of EPO [18-20]. We
have also produced transgenic pigs expressing hEPO
protein in the mammary gland, and showed that the
purified hEPO had erythropoietic activity [21]. However,
there has been no report on the generation of transgenic
mice expressing the dHuEPO form. In the present study,
we produced tg mice expressing dHuEPO, which was
constructed by linking 2 human EPO molecules using a
2-amino acid peptide linker. dHuEPO tg mice developed
excessive erythrocytosis that led to short lifespan,
debility, and abnormal splenomegaly. Further, by micro-
array analysis, we have identified 2,672 genes associated
with splenomegaly.
Methods
Construction of the dHuEPO gene
The N-terminal EPO domain of the human EPO dimer-
encoding construct was amplified by polymerase chain
reaction (PCR) with a plasmid containing the human
E P Oc D N A[ 1 2 ]u s i n gt h ep r i m e r sE P O1( 5 ’-TGG
TCG ACA CCA TGG GGG TGC ACG AAT GTC CT-
3’), which contains the SalIs i t ea tt h e5 ’ end, and EPO
2( 5 ’-AGG ATA TCT CTG TCC CCT GTC CTG CAG
GC-3’), which contains the Asp-Ile ligation site that was
used to ligate 2 EPO molecules. With the exception of
the stop codon, the complete EPO open-reading frame
is present in this domain. The C-terminal EPO domain
was constructed using the primers EPO 3 (5’-ATG ATA
TCG CCC CAC CAC GCC TCA TC-3’), which contains
the Asp-Ile ligation site and in which the signal
sequence was removed, and EPO 4 (5’-TAC TCG AGT
TCA TCT GTC CCC TGT CCT GCA-3’), which con-
tains the SalIs i t ea tt h e3 ’ end. This domain also con-
tains the complete open-reading frame but not the
signal sequence. The plasmid was constructed by liga-
tion of the 6 nucleotide residues encoding the peptide
linker fragment (Asp and Ile). The dimeric EPO mole-
cule was constructed by the overlapping PCR method as
previously reported [22]. The first PCR was performed
using primers EPO 1-2 and 3-4. The resulting fragments
were digested by XhoI/SalI and ligated into the unique
XhoI site of the expression vector pBC1 under the con-
trol of the goat b-casein promoter (designated as pBC1-
dHuEPO). The direction of the ligated fragment was
confirmed by restriction mapping using XhoIa n dSalI.
The sequence of the entire dHuEPO cDNA was verified
by automated DNA sequencing performed as previously
reported [22].
Production and screening of transgenic mice
Tg mice were obtained by pronuclear microinjection of
the dHuEPO cDNA driven by the goat b-casein promo-
ter; microinjection was performed as previously
described [23]. C57BL/6 N mice were used for the
experiment. All mice were raised and maintained in the
facilities of Macrogen Laboratories (Seoul, Korea).
Potential tg mice were screened using genomic DNA
samples obtained from tail biopsies. The PCR primers
were as follows: EPO-1 F, 5’-CCC AGA ATC TAA
GCG ATA TCT GGC-3’ and EPO-1R, 5’-GCC CAG
GAC TGG GAG GCC CAG AGG-3’.P C Rw a sp e r -
formed over 35 cycles (1 min at 94°C, 1 min at 56°C,
and 1 min at 72°C). The predicted PCR product was
607 bp in length. The tg mice were bred by mating het-
erozygous male/female mice with wild-type females/
males. The experiments were conducted according to
the Guidelines for the Care and Use of Laboratory Ani-
mals, Hankyong National University.
Blood analysis
Blood samples of the control and tg mice were obtained
by heart puncture, collected in heparinized tubes, and
placed on ice immediately. We examined 100 μLo f
blood on a HEMAVET 950 Automatic Cell Counter.
Hematologic parameters examined included white blood
cell (WBC) count, RBC count, and hematocrit (HCT).
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analysis
Isolation of total RNA of frozen hearts, kidneys, livers,
lungs, and spleens was performed using the TRIzol
method (Invitrogen, Carlsbad, CA) according to the
manufacturer’s specifications. The final RNA sample
was treated with DNase to prevent DNA contamination.
For RT-PCR analysis, the reverse transcription reaction
was performed with 8 μgo ft o t a lR N Au s i n gS u p e r -
Script II Reverse Transcriptase and oligo(dT) primers
according to the manufacturer’s protocols. Two microli-
ters of cDNA were used in each PCR reaction. The
dHuEPO gene was detected using a forward primer (5’-
ATG AGA ATA TCA CTG TCC CA-3’) and a reverse
primer (5’-GTG TCA GCA GTG ATT GTT CG-3’),
which yielded 304- and 808-bp DNA fragments, respec-
tively. The PCR conditions were 30 cycles of 30 s at 94°
C, 30 s at 56°C, and 30 s at 72°C. Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) was used for nor-
malization of the dHuEPO expression, and the following
GAPDH primer sequences were used for the normaliza-
tion procedure: forward, 5’-ACC ACA GTC CAT GCC
ATC AC-3’ and reverse, 5’-TCC ACC ACC CTG TTG
CTG TA-3’. The expected PCR fragment had a length
of 452 bp. The PCR conditions were 26 cycles of 10 s at
98°C, 2 s at 55°C, and 20 s at 72°C.
Splenectomy and histological analysis
Necropsy of the transgenic mice showed severe spleno-
megaly. The spleen was quickly removed for RNA pre-
paration. Samples were kept in liquid nitrogen and
stored individually at -80°C. The weight of the spleens
of wild-type (wt) and tg mice was determined. Mice
were necropsied, and the freshly dissected tissues from
spleens were fixed in 10% formalin solution. Fixed speci-
mens were embedded in paraffin and then cut into 4-
μm-thick sections. The sections were stained with
hematoxylin and eosin (H&E) according to standard
protocols.
Microarray analysis
Total RNA was extracted using the TRIzol reagent and
purified using RNeasy columns (Qiagen, Valencia, CA)
according to the manufacturer’sp r o t o c o l .A f t e rD N a s e
digestion and clean-up procedures, the RNA samples
were quantified, aliquoted, and stored at -80°C until use.
For quality control, RNA purity and integrity were eval-
uated by performing denaturing gel electrophoresis and
obtaining the optical density (OD) 260/280 ratio; these
analyses were performed on an Agilent 2100 Bioanalyzer
(Agilent Technologies, Palo Alto, CA).
Labeling and purification
Total RNA was amplified and purified using the
Ambion Illumina RNA amplification kit (Ambion,
Austin, TX) to yield biotinylated cRNA according to the
manufacturer’s instructions. Briefly, 550 ng total RNA
was reverse-transcribed to cDNA using a T7 oligo(dT)
primer. Second-strand cDNA was synthesized, in vitro
transcribed, and labeled with biotin-NTP. After purifica-
tion, the cRNA was quantified using the ND-1000 Spec-
trophotometer (NanoDrop, Wilmington, DE).
Hybridization and data export
We hybridized 750 ng of labeled cRNA samples to each
Mouse-8 Expression Bead array for 16-18 h at 58°C
according to the manufacturer’s instructions (Illumina,
Inc., San Diego, CA). The detection of the array signals
was performed using Amersham Fluorolink streptavidin-
Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK)
in accordance with the bead array manual. Arrays were
scanned with an Illumina Bead Array Reader confocal
scanner according to the manufacturer’si n s t r u c t i o n s .
Array data were exported and analysis was performed
using Illumina BeadStudio v3.1.3 (Gene Expression
Module v3.3.8).
Raw data preparation and statistical analysis
The quality of hybridization and overall chip perfor-
mance was monitored by visual inspection of both inter-
nal quality controls and scanned raw data. The raw data
were extracted using the software provided by the man-
ufacturer (Illumina BeadStudio v3.1.3; Gene Expression
Module v3.3.8). The array data were filtered by a detec-
tion p-value < 0.05 (similar to signal-to-noise ratio) in at
least 50% of the samples (we applied a filtering criterion
for data analysis; a higher signal value was required to
obtain a detection p-value < 0.05). Selected gene signal
values were transformed using a logarithm and normal-
ized by the quantile method. The comparative analysis
between the test and control groups was performed
using the t test (adjusted Benjamini-Hochberg false dis-
covery rate [FDR], 5% controlled) and fold-change
values. Hierarchical cluster analysis was performed using
complete linkage and Euclidean distance as measures of
similarity. All data analyses and visualization of differen-
tially expressed genes were conducted using ArrayAs-
sist
® (Stratagene, La Jolla, CA) and R statistical language
v. 2.4.0. Ontology-based analysis was performed using
the Panther database [24].
Quantitative real-time PCR (qRT-PCR)
To validate the microarray data, 20 genes from different
categories, including platelet factor 4 (Pf4); Fc receptor,
IgG, low affinity IV (Fcgr4); proteoglycan 2, bone mar-
row (Prg2); haptoglobin (Hp); elastase, neutrophil
expressed (Elane); tribbles homolog 3 (Trib3); S100 cal-
cium binding protein A9 (calgranulin B) (S100a9);
pleckstrin 2 (Plek2); formyl peptide receptor 2 (Fpr2);
histocompatibility 2, class II, locus Mb2 (H2-DMb2);
chemokine (C-X-C motif) receptor 5 (Cxcr5); Fc
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(Cfd); C-type lectin domain family 4, member g
(Clec4g); chemokine (C-C motif) receptor 6 (Ccr6);
CD79B antigen (Cd79b); CD40 antigen (Cd40); CD6
antigen (Cd6); and inositol 1, 4, 5-triphosphate receptor
2( Itpr2), were chosen for qRT-PCR analyses. Primer
sequences and primer annealing temperatures are out-
lined in Table 1. Primers were designed using Primer3
software [25]. One microgram of total RNA was reverse
transcribed to cDNA using oligo(dT) primers with the
first-strand cDNA synthesis kit for RT-PCR (Invitrogen)
according to the manufacturer’s instructions. qRT-PCR
was performed in a Rotor-Gene™ 6000 (Corbett Life
Science, Mortlake, Australia). The reaction mixture con-
sisted of 100 ng DNA, 4 nM of each primer, and 10 ×
qPCR Mastermix Plus (Toyobo, Osaka, Japan) in a total
volume of 20 μL. A negative control containing all
reagents minus DNA was included in each run. All reac-
tions were performed with an initial denaturation for 10
min at 95°C followed by 40 cycles of 95°C for 10 s, the
respective annealing temperature (Table 1) for 15 s, and
72°C for 20 s. The housekeeping gene b-actin was run
in parallel. The threshold cycle number and reaction
efficiency were determined using the Rotor-Gene 6000
series software version 6.1.93; the 2
-DDCTm e t h o dw a s
used for relative quantitation. Absence of primers and
the presence of the correct amplicon size for the specific
SYBR green assays were verified by melting-curve
analysis.
Results
Production of dHuEPO tg mice
A total of 1,018 1-cell stage embryos were transferred to
52 recipient mice on day 1 of the estrous cycle (Table
2). Spontaneous abortion occurred in 23 recipients dur-
ing mid-to-late pregnancy. Twenty-nine recipients (56%)
successfully farrowed after embryo transfer. Thirty mice
died soon after birth. The mortality rate of the tg mice
was 39%, about 8-fold higher than that of the control
wt mice. Forty-seven live mice were screened. Three tg
mice were identified by transgene-specific PCR. Three
positive transgenic founder lines, i.e., #3, #11, and #47,
were obtained. One of these founders was female (#3)
and the other 2 were male (#11, #47). All these foun-
ders produced offspring. PCR analysis of tail DNA sam-
p l e sr e v e a l e dt h a to n l y1( # 1 1 )o ft h e3l i n e sw a s
positive. Two offspring (F1) (1 male, 1 female) of this
founder (#11) were positive for the dHuEPO gene. Five
mice were born from the F1 male, of which 3 (F2; 2
male, 1 female) were positive for the dHuEPO gene.
The tg males (line #11), including F1 and F2 males, had
a short life span. The average lifespan of male mice was
71-72 days. The remaining 2 female mice (F1, F2)
developed a moribund condition. Moreover, the F1 and
Table 1 The primer sets for genes used in qRT-PCR
NCBI
ACCESSION
NUMBER
Forward Tm Reverse Tm size
(bp)
I NM_019932 CCGAAGAAAGCGATGGAGAT 57.3 TTCAGGGTGGCTATGAGCTG 59.3 139
NM_144559 CCGTGGCATCAAATCACATT 59.4 CCTGAGGTTCCTTGCTCCAT 58.9 145
NM_008920 CTTGCCTAGGGATGCAGAGA 59.4 ATCCTGACCTGAGACAGCTC 59.4 144
NM_017370 GTGCCCGAGAAGAAAAACTTG 57.9 AGGTGTCCTCCTCCATGTCA 59.4 154
NM_015779 GAGGCTGTGGATCTGGATTG 59.4 TCCTAGTTGGTCCTGCCCT 58.8 139
II NM_144554 GGAGAACCTGGAAGATGCCT 59.4 GATCTTGCCAAAGAGCAGGA 57.3 142
NM_175093 ACGACTCTGAGCCAGTCCT 58.8 CCACAAGTCGCTCTGAAGGT 59.4 132
NM_009114 GACACCCTGAGCAAGAAGGA 59.4 AGCTCAGCTGATTGTCCTGG 59.4 139
NM_013738 AGGGGCACAAGAGGAAAAAC 57.3 ACACAAGGGAACCACGAAGA 57.3 135
NM_008039 GCCAGGACTTTCGTGAGAGA 59.4 CTTCATGGGGCCTTTAACTCA 57.9 142
III NM_010388 TGGCTTTGTGGCTCATGTGG 59.4 CACCCCAAATTCACAGGGGA 59.4 148
NM_007551 AACCGAGACCTTCCTGTTCC 59.1 TGTGCAGAGCGATCACAGTT 59 134
NM_145141 GCAACCCAGATGTTACTGGC 59.1 CAGCTTCACTGGATTGGGTC 59.2 145
NM_013459 ATCATGAACCGGACAACCTG 57.3 AACCACACCTTCGACTGCAT 57.3 150
NM_029465 AAGCGCCAGAACAGCTCCT 58.8 ATCACCAGATGGGCACCCT 58.8 139
IV NM_009835 GCTTTCCTGCATTGCTGCCT 59.4 TAAACCCGGGCACAGAGGAA 59.4 143
NM_008339 ACAAGGATGACGGCAAGGC 58.8 ATTCCTGGCCTGGATGCTC 58.8 144
NM_170702 ACAGCGGTCCATCTAGGGCA 61.4 CATGGGTGGCATTGGGTCTT 59.4 140
NM_009852 CAACTTGGAACTGGCTGGC 58.8 AGGGGGTCCTGGACATTCA 58.8 148
NM_019923 TGCCGTAATCAACACCAGCG 59.4 TCTGCAGGAAGGTGTGGGCT 61.4 136
V b-actin AGAGGGAAATCGTGCGTGAC 59.3 CAATAGTGATGACCTGGCCGT 59.8 138
(Biological process: I, Immunity and defense: II, Signal transduction; Molecular function: III, Defense/immunity protein: IV, Receptor; Housekeeping gene: V, b-actin)
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pregnant. We performed autopsies on these 2 mice.
Thus, we produced a total of 5 mice carrying the
dHuEPO gene from founder #11. F1 transmission rate
from founder was 100%. F2 transmission rate from F1
male was 60% (3/5).
Blood composition of dHuEPO tg mice
Mouse blood was collected by heart puncture. Blood
analysis revealed that the RBC counts, WBC counts, and
HCT values in the dHuEPO tg mice were remarkably
higher than those in the wt mice (Figure 1). The total
WBC count was higher in the blood of tg mice (wt, 1.93
±0 . 0 8×1 0
3/μL vs. tg F1, 13.43 ± 0.97 × 10
3/μLa n dt g
F2, 10.77 ± 0.21 × 10
3/μL). Similarly, the RBC count
was higher in tg than in wt mice (wt, 9.43 ± 1.03 × 10
6/
μL vs. tg F1, 17.97 ± 0.03 × 10
6/μLa n dt gF 2 ,1 3 . 5 7±
0.21 × 10
6/μL). Notably, we also found that the HCT
value was significantly higher in tg mice than in wt mice
(wt, 47.75 ± 3.46% vs. tg F1, 74.9 ± 0.14% and tg F2,
63.45 ± 0.92%).
Expression of dHuEPO mRNA in tg mice
We examined dHuEPO mRNA expression in various
organs, and detected it using RT-PCR in the heart, kid-
ney, liver, lung, and spleen (Figure 2). The 304- and
808-bp PCR amplicons were visualized on an agarose
gel. The obtained PCR bands matched the predicted
sizes. The expected PCR band was detected in most of
the tissues examined indicati n gt h a tt gm i c ee x p r e s s e d
the dHuEPO gene in several tissues. We did not detect
any PCR band in the wt mice.
Tg mice showed distinct splenomegaly and an increased
red pulp area
The distinct differences in the spleens of tg mice are
shown in Figure 3. Tg mice exhibited severe splenome-
galy. The wet weights of spleens from the F1 and F2 tg
mice were 21- and 11-fold higher than those of the
spleens from wt mice (Figure 3A). When take the
spleen, F1 female was 157 days in age and F2 female
was 72 days in age. Thus, the spleen weight is difference
between two mice. We observed H&E-stained sections
of spleens of F1 tg, F2 tg, and wt mice (Figure 3B). The
spleens of F1 tg and F2 tg mice were easily distinguish-
able from spleens of the wt mice. The tg spleens showed
a greater red pulp area than did wt spleens.
Microarray image and data analysis
Using the microarray analysis tool, we assessed statistically
significant variations in the expression levels of the 2,672
candidate genes (Figure 4A). In comparison with the
expression in the wt control mice, 764 genes were upregu-
lated and 849 were downregulated in spleens of F1 tg
mice, 1,155 genes were upregulated and 1,164 were down-
regulated in F2 tg mice; and 20 genes were upregulated
and 243 were downregulated in both F1 tg and F2 tg mice.
Figure 4B shows the heat map (displaying differential
expression levels) and hierarchical clustering of the chosen
genes. The horizontal rows of the heat map represent
genes, whereas the columns represent samples. Each pixel
represents the expression of 1 gene in 1 experiment. Red
represents upregulation, and green represents downregula-
tion of gene expression, relative to wt levels. A greater por-
tion of the heat map is green.
Table 2 Embryo transfer and pregnancy rates of microinjected embryos
No. of 1-cell stage
Transferred
No. of recipients farrowed/
no. of recipients
(%)
No. of screened live offspring
(%)
No. of founders
(positive)
(%)
1018 29/52
(56)
47
(4.6)
3
(6.4)
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Figure 1 Blood cell counts of dHuEPO transgenic mice. Hematological parameters showed that tg mice had markedly increased RBC, WBC,
and HCT values. All data are mean ± SD. A: HCT (%); B: RBC (× 10
6/μL); C: WBC (× 10
3/μL). HCT: hematocrit; RBC: red blood cell; WBC: white
blood cell; F1 (tg): F1 female mice produced from founder #11; F2 (tg): F2 female mice produced from F1 founder male.
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associated genes
We used the Panther database to assign gene ontology
(GO) categories to the 2,672 genes showing significant
transcriptional differences between wt and tg mice. The
categorization of splenomegaly-associated genes accord-
ing to the molecular function and biological process is
shown in Figure 5. Categorization based on biological




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Figure 2 Expression of dHuEPO mRNA in the tissues of the transgenic mice. No PCR bands were detected in the control mice. The
expected dimeric and monomeric PCR bands were found in the F1 (tg) and F2 (tg) mice. The mice tissues tested were heart (He), kidney (Ki),
liver (Li), lung (Lu), and spleen (Sp).


Figure 3 Morphological changes and histological analysis of the spleen in splenomegaly. A. Distinct splenomegaly-related changes were
observed in the transgenic mice. The spleen weights of the transgenic mice were remarkably higher (21-fold increase in F1 and 11-fold increase
in F2) than those of the control mice. B. Histological analysis of the spleen of the transgenic and control mice. Paraffin sections were stained
with hematoxylin & eosin (original magnification, × 400).
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Page 6 of 12processes revealed that the responsive genes were
related to 29 biological processes, including signal trans-
duction (16%), nucleoside, nucleotide, and nucleic acid
metabolism (12%), immunity and defense (11%), protein
metabolism and modification (9%), developmental pro-
cesses (7%), cell cycle (6%), and cell structure and moti-
lity (5%) (Figure 5A). In the categorization based on
molecular function, the genes were classified into 27
categories, as shown in Figure 5B. The most over-repre-
sented GO categories were concerned with nucleic acid
binding (14%), receptors (9%), transcription factors (8%),
select regulatory molecules (7%), and signaling mole-
cules (5%). Additionally, we functionally categorized
transcripts that showed a >5.0-fold increase in expres-
sion (data not shown). In this categorization, we
obtained 12 categories for genes involved in biological
processes, including signal transduction, immunity and
defense, protein metabolism and modification, and
nucleoside, nucleotide, and nucleic acid metabolism, and
13 categories for genes involved in molecular functions,
including cytoskeletal proteins, defense/immunity pro-
teins, and hydrolases. A total of 25 genes were classified,
and we represented a range of changes observed in
microarray studies (5.12- to 44.57-fold changes for upre-
gulated genes; data not shown). A partial list of the
transcripts that showed a <-5.0-fold change (decrease) in
expression was also obtained (data not shown). Twenty-
four of the gene categories in this list were associated
with biological processes such as immunity and defense
(34%), signal transduction (26%), developmental pro-
cesses (8%), and protein metabolism and modification
(5%), and 21 categories of genes were associated with
molecular functions such as defense/immunity proteins
(33%), receptors (32%), signaling molecules (14%), and
kinases (12%). In this categorization, a total of 153 genes
were classified that represented a range of changes
observed in microarray studies (-5.01- to -81.38-fold
changes for repressed genes; data not shown).
Independent microarray validation using RT-PCR and qRT-
PCR
Among all the cDNAs identified in the microarray
study, we decided to narrow the search for candidate
genes to 20 genes specific to the spleen (Table 3). These
candidate genes were chosen according to the specific
selection criterion of having a low or high impact on
biological processes and molecular functions, e.g., genes
associated with receptors, signal transduction, and
immunity/defense. RT-PCR and qRT-PCR were con-
ducted to validate the microarray results for the mRNA
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Figure 4 Microarray image and data analysis. A. Statistical significance of each correlation coefficient was determined using a corrected
(Benjamini & Hochberg algorithm) P value (P < 0.05). B. Heat map and cluster analysis of gene expression measurements normalized to a single
array showing genes in rows and samples in columns. Columns 1, 2: control mice; columns 3, 4, 5: F2 (tg); columns 6, 7, 8: F1 (tg); Con, control;
tg, transgenic.
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Page 7 of 12levels of the selected 20 clones (Figure 6). The 20 genes
showed significantly different expression. The transcript
abundance patterns of the control and tg mice were
compared with the microarray data. All the genes ana-
lyzed showed the same expression patterns by qRT-PCR
as noted in the microarray data. Figure 6 shows the
expression levels of the 20 genes (10 genes showing
upregulation and 10 showing downregulation). For
example, in comparison with its expression in wt mice,
the Pf4 gene (NM_019932) showed 5.4- to 5.8-fold
upregulation in tg mice by qRT-PCR, consistent with
t h e3 . 8 -t o4 . 9 - f o l dh i g h e re x p r e s s i o ns e e ni nt gm i c ei n
the microarray data. Furthermore, the expression pro-
f i l e so f1 0g e n e s ,i n c l u d i n gH2-DMb2 (NM_010388),
and 4 other genes with significant transcriptional
changes, including [Cxcr5 (NM_007551), Fcrla
(NM_145141), Cfd (NM_013459), and Clec4g
(NM_110691)], were analyzed in the spleens of the con-
trol and tg mice. As expected, all these genes were
downregulated in tg mice. Noticeably, the expression
level of the H2-DMb2 (NM_010388) gene was 50-100-
fold lower in tg mice than in wt mice.
Discussion
The dimer of 2 human EPO molecules linked by peptide
linkers shows higher erythropoietic activity than the
monomeric molecule, and this enhanced activity was
observed both in vitro in primary human erythroid pro-
genitors and in vivo in normal mice [7,9]. On the basis
of these results, an expression vector producing
dHuEPO protein was constructed to utilize the fusion
system of 2 human EPO molecules linked by a peptide
Figure 5 Functional categorization of the genes showing significant transcriptional differences in the transgenic and control mice.A
total of 2,672 genes were categorized on the basis of Gene Ontology (GO) annotation, and the proportion of each category is displayed on the
basis of biological process (A) and molecular function (B).
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Page 8 of 12linker of 2 amino acids (Asp-Ile). Several medical pro-
teins have been successfully produced using goat pro-
moter systems. Using the goat b-casein promoter,
therapeutic proteins have been expressed at high levels
in the milk of tg mice [26]. We designed the dHuPEO
gene by recombinant DNA-mediated fusion of EPO
coding regions linked by the Asp-Ile peptide and ana-
lyzed the physiological characteristics of the dHuEPO
transgenic mice. The dHuEPO tg mice exhibited spleno-
megaly and abnormal blood composition. The inserted
dHuEPO gene was detected in all mouse tissues tested.
Most of the tg mice tended to show abnormal symp-
toms, e.g., short life span. We identified 2,672 candidate
genes in the spleen by microarray analysis; more genes
were downregulated than upregulated in tg mice show-
ing splenomegaly.
We found that the spontaneous abortion rate was high
in the tg mice. Twenty-nine recipients (56%) successfully
farrowed after dHuEPO tg embryo transfer. Song et al.
[27] reported that lanosterol 14a-demethylase (LDM) is
selectively expressed in preimplantation embryos and
the uterine subluminal stroma surrounding the implant-
ing blastocyst on day 5 of pregnancy. A high level of
LDM expression is also observed in the uterus deciduas
on day 6-8 of pregnancy, indicating that LDM is closely
related to mouse embryo implantation. Therefore,
dHuEPO embryos maybe have perturbation in sterol
biosynthesis and metabolism during the peri-implanta-
tion period, leading to a high rate of spontaneous abor-
tion or death. We observed that tg males, including F1
and F2 individuals, had a short life span. Several groups
have reported premature mortality in polycythemic mice
[18,28-30]. In contrast, other groups did not observe
shortened life span in a series of human EPO tg mouse
lines with elevated mean HCTs ranging from 48% to
80% [31-33]. In the present study, the F1 and F2 tg
mice tested had HCT values of 74% and 63%, respec-
tively. The HCT values of the tg mice were markedly
higher than that of the controls (47%). Madan et al. [34]
suggested that different mouse strains may differ in
their ability to tolerate the rheological and hemody-
namic effects of increased blood viscosity due to an ele-
vated HCT. Kim et al. [35] reported that the life span of
hEPO tg mice may be affected, and these animals may
die of microcytic anemia and acute leukemia. The tg
females (F1/F2) experienced spontaneous abortion dur-
ing mid-to-late pregnancy. Thus, we were unable to
obtain dHuEPO protein in their milk. Toth et al. [36]
reported that EPO-receptor (EPO-R) expression in the
villous trophoblast of the abortion tissue in tg mice was
significantly higher than the normal EPO-R levels in
humans. Although there is no experimental evidence to
support the direct cause of these abortions, it is possible
that the expression of EPO-R is upregulated in the pla-
centa of the abortion tissue. EPO levels in the amniotic
fluid correlate well with the EPO levels in the cord
plasma and are significantly higher in pregnancies com-
plicated by hypertension than in normal pregnancies
[37].
T h ee c t o p i ce x p r e s s i o no fat r a n s g e n ec a nb ei n f l u -
enced by the site of integration, the absence of specific
regulatory elements in the promoter, and the presence
of negative regulatory elements [38,39]. Ectopic expres-
sion of the EPO gene has been shown to cause harmful
effects on the survival, health, and growth of some tis-
sues in tg mice [35,40]. In our study, tg mice expressed
dHuEPO mRNA in a variety of tissues, including the
heart, kidney, liver, lung, and spleen. Thus, it is possible
that ectopic expression of dHuEPO caused multiple
organ failure in tg mice. F1 and F2 tg mice showed sple-
nomegaly, and the weight of the spleen increased by 21-
and 11-fold, respectively. A previous study reported that
enhanced erythropoiesis occurred in tg spleens, accom-
panied by an up to 5-fold increase in weight [20]. In
studies of inpatients with splenomegaly, hematological
Table 3 Genes differing in their expression levels
between control and tg (F1 or F2) spleen
No. NCBI
Accession
Number
Gene F1/
Con
F2/
Con
Elevated in tg
1 NM_019932 Platelet factor 4 4.98 3.86
2 NM_144559 Fc receptor, IgG, low affinity IV 10.46 2.04
3 NM_009921 Cathelicidin antimicrobial peptide 16.80 7.96
4 NM_017370 Haptoglobin 10.41 1.77
5 NM_015779 Elastase, neutrophil expressed 15.81 3.81
6 NM_144554 Tribbles homolog 3 44.57 31.60
7 NM_175093 Tribbles homolog 3 (Drosophila) 8.93 6.82
8 NM_009114 S100 calcium binding protein A9 7.72 4.95
9 NM_013738 Pleckstrin 2 5.30 6.50
10 NM_008039 Formyl peptide receptor 2 8.97 2.33
Reduced in tg
11 NM_010388 Histocompatibility 2, class II, locus
Mb2
-32.53 -19.50
12 NM_007551 Chemochine (C-X-C motif) receptor
5
-25.45 -14.77
13 NM_145141 Fc receptor-like A -22.73 -15.10
14 NM_013459 Complement factor D (adipsin) -21.51 -15.43
15 XM_110691 C-type lectin domain family 4,
member g
-14.94 -6.47
16 NM_009835 Chemokine (C-C motif) receptor 6 -41.86 -17.43
17 NM_008339 CD79B antigen -23.98 -20.22
18 NM_170702 CD40 antigen -11.54 -10.61
19 NM_009852 CD6 antigen -11.11 -16.07
20 NM_019923 Inositol 1,4,5-triphosphate receptor
2
-4.04 -5.03
Gene names correspond to their Unigene identification where possible, and
otherwise their Affymetrix identifier. Genes are displayed from the greatest to
least fold-change and the specified tg/control expression ratio is indicated
Yun et al. Reproductive Biology and Endocrinology 2012, 10:6
http://www.rbej.com/content/10/1/6
Page 9 of 12diseases were positively associated with lymphadenopa-
thy, massive splenomegaly, and cytosis (erythrocytosis,
leukocytosis, and thrombocytosis) [41,42]. O’Reilly et al.
[43] reported that 84% of the cases with progressive
splenic enlargement were associated with hematological
disease, predominantly malignancy. In the present study,
the RBC counts were higher in the tg mice than in the
controls, which might have caused an increase in the
spleen weight of the tg mice carrying the dHuEPO gene.
The tg spleens showed a higher red pulp area than did
wt spleens. Histological analysis revealed extramedullary
erythropoiesis in the spleen, and erythropoietic activity
was visualized using the monoclonal antibody ER-HR3
[20]. Our data indicated a similar incidence of massive
splenic erythropoiesis in tg mice. Both extramedullary
erythropoiesis and splenomegaly could cause classic
complications in human patients suffering from poly-
cythemia vera [44]. In the present study, we found that
the HCT values in tg mice were higher than those in
the controls (wt, 47% vs. tg F1, 74% and tg F2, 63%).
Similar to these observations, the HCT values increased
from 0.41 to 0.89 in tg mice. HCT levels of splenecto-
mized tg mice were reduced by about 30% from 0.89 to
0.62 [20]. Most of the EPO tg mice showed severe nerve
fiber degeneration of the sciatic nerve, a decreased num-
ber of neuromuscular junctions, and degeneration of
skeletal muscle fibers. Thus, chronically increased EPO
levels induced excessive erythrocytosis and led to multi-
ple organ degeneration, thereby providing an explana-
tion for the reduced life expectancy [19]. Erythrocyte
aging of EPO tg mice was observed to be accelerated,
which, together with an increased number and activity
of macrophages, resulted in enhanced erythrocyte clear-
ance [18]. These results indicate that extramedullary
erythropoiesis can cause splenomegaly in tg mice.
A number of studies have employed microarray tech-
nology to characterize gene expression profiles [45-47].
Accordingly, this study was designed to provide data on
AC
D B
Figure 6 Validation of independent microarray data using RT-PCR and qRT-PCR. A.U p r e g u l a t e dg e n e si nt gm i c ei n c l u d e d5s e l e c t e d
genes involved in defense and immunity. B. Upregulated genes involved in signal transduction in tg mice. C. Downregulated genes related to
defense and immunity proteins in tg mice. D. Downregulated genes associated with receptors in tg mice. The relative expression levels were
analyzed by RT-PCR (left) and real-time PCR (right). Columns and bars represent the means and standard error (n = 3) respectively. tg, transgenic.
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of dHuEPO tg mice. Our results showed that a total of
2,672 genes were differentially expressed in the spleen
of tg mice, in comparison to their expression in the con-
trols. Furthermore, the expression of 153 of these genes
(< 5-fold change, P< 0.05) was repressed, and the
expression of 25 genes (>5-fold change, P< 0.05) was
promoted. The tg spleens had more downregulated
genes than the controls, including genes for defense/
immunity proteins and receptor-related genes; this sug-
gests that the spleen is a major site for immunological
elimination. Commonly used techniques for validation
of microarray data include RT-PCR, qRT-PCR, northern
blot, ribonuclease protection assay, and in situ hybridi-
zation or immunohistochemistry [48]. We used RT-PCR
and qRT-PCR to validate our microarray data. Although
the standard deviations in the expression levels of vali-
dated genes tended to be different, they matched the
microarray patterns for the most part. These changes in
gene expression profiles may provide a molecular frame-
work to explain the complex differences in the splenic
phenotypes of dHuEPO tg mice. Moreover, these results
p r o v i d eag l o b a lp i c t u r eo fg e n ee x p r e s s i o nd i f f e r e n c e s
in splenomegaly.
Conclusions
We generated dHuEPO tg mice using the goat b-casein
promoter system, but this system had a negative effect
on survival. Moreover, we were unable to obtain
dHuEPO protein from the milk of these mice. Tg mice
caused excessive erythrocytosis that led to abnormal
blood composition, short lifespan, and abnormal spleno-
megaly. We have identified 2,672 genes associated with
splenomegaly by microarray analysis in these mice.
Thus, further studie is required to define these symp-
toms (excessive erythrocytosis, short lifespan and exces-
sive splenomegaly) in dHuEPO tg mice.
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